|
|
|
1-10 employees
View all
|
|
Pharmaceuticals
|
|
Ashburn, Virginia 20148, US
|
|
Founded in 2018, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities, and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others. The company plans to establish a sales infrastructure to commercialize its products in both U.S. and Europe and seeks to enter into strategic licensing partnerships for all other territories.
We are dedicated to finding unique solutions for rare and orphan indications and will continue to expand our pipeline of products to address the unmet needs of underserved patient populations.
To learn more about Quoin Pharmaceuticals please visit our website: www.quoinpharma.com
|
Quoin Pharmaceuticals Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Quoin Pharmaceuticals email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Quoin Pharmaceuticals customer service number in your country click here to find.
Michael Myers is the CEO of Quoin Pharmaceuticals. To contact Michael Myers email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.